WHO Expert Committee on Specifications for Pharmaceutical Preparations: thirty-ninth report
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Geneva
World Health Organization
2005
|
Schriftenreihe: | Technical report series (World Health Organization)
929 |
Schlagworte: | |
Beschreibung: | "WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v Includes bibliographical references This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products |
Beschreibung: | vii, 142 p. |
ISBN: | 9241209291 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV044122757 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 170217s2005 |||| o||u| ||||||eng d | ||
020 | |a 9241209291 |9 92-4-120929-1 | ||
035 | |a (ZDB-30-PAD)EBC284792 | ||
035 | |a (ZDB-89-EBL)EBL284792 | ||
035 | |a (OCoLC)476035356 | ||
035 | |a (DE-599)BVBBV044122757 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
082 | 0 | |a 615.907 | |
245 | 1 | 0 | |a WHO Expert Committee on Specifications for Pharmaceutical Preparations |b thirty-ninth report |
264 | 1 | |a Geneva |b World Health Organization |c 2005 | |
300 | |a vii, 142 p. | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Technical report series (World Health Organization) |v 929 | |
500 | |a "WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v | ||
500 | |a Includes bibliographical references | ||
500 | |a This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products | ||
650 | 4 | |a Drugs |x Standards |v Congresses | |
650 | 4 | |a Pharmacopoeias |v Congresses | |
650 | 4 | |a Drugs |x Quality control |v Congresses | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
710 | 2 | |a World Health Organization |e Sonstige |4 oth | |
710 | 2 | |a WHO Expert Committee on Specifications for Pharmaceutical PreparationsXXn(39thXXd2004 |e Sonstige |4 oth | |
912 | |a ZDB-30-PAD | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029529602 |
Datensatz im Suchindex
_version_ | 1804177204867760128 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV044122757 |
collection | ZDB-30-PAD |
ctrlnum | (ZDB-30-PAD)EBC284792 (ZDB-89-EBL)EBL284792 (OCoLC)476035356 (DE-599)BVBBV044122757 |
dewey-full | 615.907 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.907 |
dewey-search | 615.907 |
dewey-sort | 3615.907 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02295nmm a2200397zcb4500</leader><controlfield tag="001">BV044122757</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2005 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9241209291</subfield><subfield code="9">92-4-120929-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC284792</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL284792</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)476035356</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044122757</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.907</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations</subfield><subfield code="b">thirty-ninth report</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Geneva</subfield><subfield code="b">World Health Organization</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">vii, 142 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Technical report series (World Health Organization)</subfield><subfield code="v">929</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Standards</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacopoeias</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Quality control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">World Health Organization</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical PreparationsXXn(39thXXd2004</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029529602</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV044122757 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:44:22Z |
institution | BVB |
isbn | 9241209291 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029529602 |
oclc_num | 476035356 |
open_access_boolean | |
physical | vii, 142 p. |
psigel | ZDB-30-PAD |
publishDate | 2005 |
publishDateSearch | 2005 |
publishDateSort | 2005 |
publisher | World Health Organization |
record_format | marc |
series2 | Technical report series (World Health Organization) |
spelling | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report Geneva World Health Organization 2005 vii, 142 p. txt rdacontent c rdamedia cr rdacarrier Technical report series (World Health Organization) 929 "WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 25-29 October 2004"--P. v Includes bibliographical references This report discusses the monographs on antiretrovirals proposed for inclusion in The International Pharmacopoeia and specifications for radiopharmaceuticals, quality specifications for antituberculosis drugs and the revision of the monograph on artemisinin derivatives, as well as quality control of reference materials, good manufacturing practices, inspection, distribution and trade, and other aspects of quality assurance of pharmaceuticals, and regulatory issues. Several annexes include an amendment to good manufacturing practices: main principles regarding the requirement for the sampling of starting materials, guidelines on good manufacturing practices regarding water for pharmaceutical use, guidelines on the sampling of pharmaceutical products, and draft guidelines for registration of fixed-dose combination medicinal products Drugs Standards Congresses Pharmacopoeias Congresses Drugs Quality control Congresses (DE-588)1071861417 Konferenzschrift gnd-content World Health Organization Sonstige oth WHO Expert Committee on Specifications for Pharmaceutical PreparationsXXn(39thXXd2004 Sonstige oth |
spellingShingle | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report Drugs Standards Congresses Pharmacopoeias Congresses Drugs Quality control Congresses |
subject_GND | (DE-588)1071861417 |
title | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report |
title_auth | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report |
title_exact_search | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report |
title_full | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report |
title_fullStr | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report |
title_full_unstemmed | WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report |
title_short | WHO Expert Committee on Specifications for Pharmaceutical Preparations |
title_sort | who expert committee on specifications for pharmaceutical preparations thirty ninth report |
title_sub | thirty-ninth report |
topic | Drugs Standards Congresses Pharmacopoeias Congresses Drugs Quality control Congresses |
topic_facet | Drugs Standards Congresses Pharmacopoeias Congresses Drugs Quality control Congresses Konferenzschrift |
work_keys_str_mv | AT worldhealthorganization whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyninthreport AT whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsxxn39thxxd2004 whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyninthreport |